Scanwell Health
Scanwell Health is an FDA-cleared digital health company founded in 2018 in Los Angeles that provides a smartphone-based urine testing application, using computer vision to read at-home diagnostic test strips for patients and clinical users.
- Company typePrivate
- Founded2018
- HeadquartersLos Angeles, United States
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
What Scanwell Health does
Scanwell Health is a privately held, FDA-cleared digital health company founded in 2018 and headquartered in Los Angeles. Its core product is a smartphone application that uses the device camera and computer-vision software to read and interpret at-home urine test strips, converting colorimetric results into clinically actionable readings. The company sits at the intersection of regulated medical software and consumer diagnostics, addressing conditions historically associated with urine-based screening such as urinary tract infections and chronic kidney disease monitoring, though specific indications served are not detailed in the available sources.
The company is led by founder & CEO Stephen Chen, with Pavel Bozdog serving as CTO and Andrew Hosford as head of engineering, reflecting a product- and engineering-led operating model appropriate for a regulated software company. The technology stack is centered on smartphone-based image capture and proprietary interpretation algorithms validated through FDA clearance, which constitutes the primary technical and regulatory differentiator from generic urine dipstick readers.
Scanwell's business model is not disclosed in detail in the available sources — there is no published pricing, no named customer or payer relationships, and no explicit revenue mechanics on file. The product's positioning as a direct-to-consumer diagnostic application implies either a consumer-pay or payer-reimbursement model, but the source data does not confirm which path the company is actually commercializing. The company has raised approximately $3.62M in cumulative disclosed funding across three 2018–2019 rounds, with the November 2019 round of $3.5M bringing in a syndicate of DCM Ventures, Founders Fund, Inovia Capital, Liquid 2 Ventures, Mayfield Fund, Version One Ventures, and Y Combinator. Headcount is reported at 11–50 employees, consistent with an early-stage operating profile.
Scanwell Health firmographics
Firmographics- Name
- Scanwell Health
- Website
- https://scanwellhealth.com
- Company type
- Private
- Founded year
- 2018
- Headcount range
- 11–50 employees
- Short description
- Scanwell Health is an FDA-cleared digital health company founded in 2018 in Los Angeles that provides a smartphone-based urine testing application, using computer vision to read at-home diagnostic test strips for patients and clinical users.
- Ownership category
- akta.pro rank
Scanwell Health industry classification
Industry- Product category
- Digital Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Urinalysis & Routine Screening Diagnostics (HLAHAAAG)
- akta.pro secondary industries
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Renal Diagnostics & Monitoring (eGFR/Creatinine POC, Urine Analyzers, BP/Fluid Status) (HLAHAKAJ)
Keywords
Where Scanwell Health is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Markets served
Scanwell Health business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations
Scanwell Health product offering
Product offeringCore offering
Scanwell Health sells an FDA-cleared urine testing application that lets users conduct clinical-grade urinalysis at home using a smartphone camera and a physical test strip kit. The product combines a mobile app with consumable test kits to deliver results for at-home screening and remote patient monitoring, primarily targeting consumers and telehealth/healthcare partners.
Differentiator
Problem solved
Functional benefit
Products and services
- Scanwell Urine Testing App FDA-cleared mobile application that uses a smartphone camera and computer vision to read urine test strips at home, delivering clinical-grade urinalysis results for individual consumers and telehealth use cases such as UTI screening and kidney health monitoring.
Companies that use Scanwell Health
Customer profileIdeal customer profiles2 records
Scanwell Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Scanwell Health partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
Scanwell Health competitors and assessment
Company assessmentDirect peers
- Healthy.io: Healthy.io is the most direct competitor, offering FDA-cleared smartphone-based at-home urine testing (Dip.io) for kidney disease, UTI, and prenatal screening. It competes head-to-head with Scanwell on the same clinical indications, distribution channels (payers, providers, pharmacies), and technology stack (app + test strip + smartphone camera).
- Everlywell: Everlywell is a leading direct-to-consumer at-home testing platform covering a broad panel of conditions including kidney function and women's health. It overlaps with Scanwell on consumer-purchased diagnostics and on the model of selling kits online with results reviewed by physicians.
- LetsGetChecked: LetsGetChecked offers a wide range of at-home diagnostic tests with lab processing and telehealth integration, including hormone, sexual health, and wellness panels. It competes with Scanwell on the consumer-facing home diagnostics purchase journey and on chronic-condition screening use cases.
Emerging players
- Cue Health: Cue Health builds connected at-home molecular and respiratory diagnostics with a consumer/professional reader. It is comparable to Scanwell as a connected home-diagnostic platform but uses a dedicated reader rather than a smartphone, representing an adjacent technology approach to home testing.
- Natalist: Natalist focuses on at-home fertility and pregnancy diagnostics and ovulation tests for women. It is comparable to Scanwell on the women's health and reproductive urine-testing category and on a direct-to-consumer go-to-market.
- Modern Fertility: Modern Fertility (acquired by Ro) offers at-home hormone and reproductive health testing with digital results. It overlaps with Scanwell on the home diagnostics + app model for women's health indications.
- Oova: Oova provides smartphone-based at-home hormone and ovulation testing using a urine test strip and AI-powered app. It is highly comparable to Scanwell on the smartphone-camera + consumable diagnostic stack, though focused on fertility.
Broad incumbents
- BinaxNOW / Abbott (at-home diagnostics): Abbott's diagnostics franchise (including BinaxNOW and other rapid tests) is a broad incumbent in point-of-care and at-home testing. It overlaps with Scanwell on the broader category of FDA-cleared rapid home diagnostics and represents both a competitor and potential acquirer/distribution partner.
- Hims & Hers Health: Hims & Hers combines telehealth subscriptions with at-home lab testing for hormone, sexual health, and primary care conditions. It competes with Scanwell for the same consumer wallet on diagnostics bundled with virtual care, particularly in UTI and women's health.
- Ro (Roman): Ro is a direct-to-patient healthcare company combining telehealth, pharmacy, and at-home diagnostics across multiple conditions. It is a broader incumbent competing with Scanwell for the same consumer use cases (UTI, sexual health, fertility) and could be a partner or competitor for B2B2C distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Scanwell Health social profiles
Digital presenceScanwell Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Scanwell Health leadership team
Management profileNumber of profiles
Profiles3 records
Scanwell Health funding detail
Funding detailFunding overview
Funding rounds3 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Scanwell Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Scanwell Health
What does Scanwell Health do?
Scanwell Health sells an FDA-cleared urine testing application that lets users conduct clinical-grade urinalysis at home using a smartphone camera and a physical test strip kit. The product combines a mobile app with consumable test kits to deliver results for at-home screening and remote patient monitoring, primarily targeting consumers and telehealth/healthcare partners.
When was Scanwell Health founded?
Scanwell Health was founded in 2018. It employs 11 to 50 people.
Where is Scanwell Health based?
Scanwell Health is headquartered in Los Angeles, United States, in the North America region.
Who are Scanwell Health's main competitors?
Direct peers on record are Healthy.io, Everlywell and LetsGetChecked. Emerging players are Cue Health, Natalist, Modern Fertility and Oova. Broad incumbents are BinaxNOW / Abbott (at-home diagnostics), Hims & Hers Health and Ro (Roman).
Does Scanwell Health have an API?
No public API is recorded for Scanwell Health.
What industry is Scanwell Health in?
Scanwell Health's product category is Digital Diagnostics. Its primary akta.pro industry code is HLAHAAAG, Urinalysis & Routine Screening Diagnostics, with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 325413 and its SIC code is 2835.